The NTS/NTSR1 complex could be used as a marker to identify subsets of human cancers, and thus make eligible new drugs, kinase inhibitors, or immunotherapy, targeting HERs protein or their downstream pathways. The gene discussed is NTSR1; the disease is cancer.